Albany, NY -- (SBWIRE) -- 05/08/2018 -- Bacillus subtilis belongs to the family of gram-positive bacteria. It is an endospore-forming bacteria that spreads into the environment. Bacillus subtilis is usually found in the outer layer of soil. It is a rod shaped protective endospore that withstands extreme environmental conditions. It is used in various applications such as food and beverage processing. Furthermore, bacillus subtilis is a prominent bacteria in enzyme production that is used commercially by biotechnology companies.
Reproduced symmetrically or asymmetrically, bacillus subtilis generates a single endospore that can remain viable for decades and is resistant to unfavorable environmental conditions such as salinity, drought, radiation, extreme pH, and solvents. Increase in demand for nontoxic products in end-use industries such as food & beverages, industrial enzymes, agriculture, aquaculture, waste treatment, and pharmaceuticals is driving the market. However, adverse health effects and implantation of various regulations on the formation of bacillus subtilis are factors restraining the market.
View Report Preview:
Based on product type, the market can be segmented into <100 billion CFU/g, 100?€"300 billion CFU/g, and > 300 billion CFU/g. The <100 billion CGU/segment is expected to dominate the market owing to its rising consumption in aquatic animal feeding and feed additives for poultry. The 100?€"300 billion CFU/g is anticipated to expand at a fast pace during the forecast period. Increase in demand for high purity and enhanced quality of products for poultry and animal feed is driving the bacillus subtilis market.
In terms of application, the bacillus subtilis market can be divided into enzymes, pesticides, and others. Bacillus subtilis is widely consumed as industrial enzyme due to its enhanced properties. Owing to its nontoxic properties, bacillus subtilis pesticides are regarded as environmentally friendly, with little or no effect on humans, wildlife, pollinators, and most other beneficial insects.
In terms of end-use industry, the bacillus subtilis market can be split into pharmaceutical, food & beverages, aquaculture, waste treatment, agriculture, and others. Food & beverages is estimated to hold significant share of the bacillus subtilis market in the near future. Bacillus subtilis is different from conventional probiotics. It has a tough outer shell that can withstand harsh processing in fruit nectars, vegetable juices, smoothies, and frozen concoctions. It also stays viable within a wide range of pH conditions and does not germinate until it reaches the right environment. Additionally, the pharmaceutical industry is projected to expand at a rapid pace during the forecast period. Due to the rising demand of bacillus subtilis in the production of membrane proteins that are widely used in biomedical and biotechnology applications.
In terms of region, the bacillus subtilis market can be segregated into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Rise in demand for high purity bacillus subtilis in countries such as China, Japan, and India is significantly boosting the bacillus subtilis market in Asia Pacific. Latin America and Middle East & Africa also account for significant market share. This can be ascribed to the increase in demand for bacillus subtilis in key industries such as pharmaceutical and food & beverages in these regions. Rise in demand for nontoxic bacterial products and changing consumer preferences are projected to augment the demand for bacillus subtilis in the near future. Presence of prominent companies catering to end-use applications of bacillus subtilis is further driving the bacillus subtilis market in North America and Europe.
The bacillus subtilis market is highly competitive owing to the presence of major local players. Competition is also influenced by shift in demand and costs. Global players are adopting research and development strategies and engaging in technological advancements in order to produce unique products. Prominent companies operating in the bacillus subtilis market include Bayer, Aumgene Biosciences, Real IPM, Wuhan Kernel Bio-Technology Co., Ltd, BASF SE, Deerland Enzymes, Inc., and Lonza.
Request to view Sample Report:
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.